Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Homologous recombination repair pathway alterations and their relationship to homologous recombination deficiency in advanced pancreatic cancer patients.
Authors
Hitendra Patel
University of California San Diego Moores Cancer Center, La Jolla, CA
Hitendra Patel , Alex Barrett , Elizabeth Mauer , Shumei Kato , Benjamin D. Leibowitz , Aatur D. Singhi , Milind M. Javle , Andrew M. Lowy
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
DOI
10.1200/JCO.2022.40.4_suppl.609
Abstract #
609
Poster Bd #
L4
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2022 ASCO Genitourinary Cancers Symposium
Immune profiling of advanced prostate cancer harboring homologous recombination deficiency.
First Author: Maryam Soleimani
Poster
2023 ASCO Annual Meeting
HRD signature and HRD genomic landscape of tumors from 896 patients with early-stage breast cancer (BC).
First Author: June Evelyn Jeon
Poster
2023 ASCO Annual Meeting
Tandem duplicator phenotype: A novel targetable subgroup in pancreatic cancer?
First Author: Abdul Rehman Farooq